McMillan Shakespeare Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de McMillan Shakespeare de 5.4% y 1.8% por año respectivamente. Se prevé que el BPA crezca en un 5.4% al año. Se espera que la rentabilidad financiera sea de 83.2% en 3 años.

Información clave

5.4%

Tasa de crecimiento de los beneficios

5.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Professional Services	15.0%
Tasa de crecimiento de los ingresos	1.8%
Rentabilidad financiera futura	83.2%
Cobertura de analistas	Good
Última actualización	26 Dec 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

The Returns At McMillan Shakespeare (ASX:MMS) Aren't Growing

Sep 17

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Sep 02

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

Feb 23

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

Jun 15

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Mar 06

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Oct 26

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Aug 31

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Jul 28

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Apr 01

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

Mar 06

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

Feb 09

Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?

Jan 19

Are Insiders Buying McMillan Shakespeare Limited (ASX:MMS) Stock?

Jan 04

Is McMillan Shakespeare Limited (ASX:MMS) Trading At A 34% Discount?

Dec 20

At AU$11.83, Is McMillan Shakespeare Limited (ASX:MMS) Worth Looking At Closely?

Dec 06

Should We Be Cautious About McMillan Shakespeare Limited's (ASX:MMS) ROE Of 1.0%?

Nov 23

McMillan Shakespeare Limited (ASX:MMS) Insiders Increased Their Holdings

Sep 13

Is Now An Opportune Moment To Examine McMillan Shakespeare Limited (ASX:MMS)?

Aug 25

Previsiones de crecimiento de beneficios e ingresos

ASX:MMS - Estimaciones futuras de los analistas y datos financieros pasados (AUD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2027	555	108	149	137	8
6/30/2026	532	104	143	130	8
6/30/2025	516	91	110	128	8
6/30/2024	521	90	-128	-106	N/A
3/31/2024	501	83	-104	-83	N/A
12/31/2023	481	76	-80	-60	N/A
9/30/2023	472	70	-36	-18	N/A
6/30/2023	464	64	8	25	N/A
12/31/2022	347	69	112	122	N/A
9/30/2022	383	68	111	121	N/A
6/30/2022	419	67	111	120	N/A
3/31/2022	601	68	114	124	N/A
12/31/2021	608	66	118	128	N/A
9/30/2021	576	63	151	162	N/A
6/30/2021	544	61	185	195	N/A
3/31/2021	508	27	221	231	N/A
12/31/2020	471	-7	257	266	N/A
9/30/2020	483	-3	215	227	N/A
6/30/2020	494	1	174	188	N/A
3/31/2020	520	32	149	166	N/A
12/31/2019	547	64	125	145	N/A
9/30/2019	548	64	119	139	N/A
6/30/2019	550	64	114	133	N/A
3/31/2019	549	57	112	130	N/A
12/31/2018	549	49	111	128	N/A
9/30/2018	547	50	107	123	N/A
6/30/2018	545	50	103	118	N/A
3/31/2018	544	56	N/A	86	N/A
12/31/2017	542	62	N/A	53	N/A
9/30/2017	533	65	N/A	50	N/A
6/30/2017	523	68	N/A	47	N/A
3/31/2017	518	76	N/A	52	N/A
12/31/2016	512	84	N/A	58	N/A
9/30/2016	508	83	N/A	76	N/A
6/30/2016	505	82	N/A	95	N/A
3/31/2016	478	79	N/A	53	N/A
12/31/2015	451	75	N/A	12	N/A
9/30/2015	420	71	N/A	-2	N/A
6/30/2015	390	67	N/A	-16	N/A
3/31/2015	379	67	N/A	20	N/A
12/31/2014	369	67	N/A	56	N/A
9/30/2014	358	61	N/A	47	N/A
6/30/2014	347	55	N/A	37	N/A
3/31/2014	339	53	N/A	37	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (5.4% al año) de MMS es superior a la tasa de ahorro (2.6%).

Beneficios vs. Mercado: Se prevé que los beneficios (5.4% al año) de MMS crezcan menos que el mercado Australian (12.6% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de MMS crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (1.8% al año) de MMS crezcan más despacio que el mercado de Australian (5.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 1.8% al año) de MMS crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de MMS sea muy elevada dentro de 3 años (83.2%).

Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

Datos	Última actualización (huso horario UTC)
Análisis de la empresa	2024/12/31 10:50
Precio de las acciones al final del día	2024/12/31 00:00
Beneficios	2024/06/30
Ingresos anuales	2024/06/30

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

Paquete	Datos	Marco temporal	Ejemplo Fuente EE.UU. ^*
Finanzas de la empresa	10 años	Cuenta de resultados Estado de tesorería Balance	Formulario SEC 10-K Formulario SEC 10-Q
Estimaciones del consenso de analistas	+3 años	Previsiones financieras Objetivos de precios de los analistas	Informes de análisis Blue Matrix
Precios de mercado	30 años	Precios de las acciones Dividendos, escisiones y acciones	Datos de mercado ICE Formulario S-1 de la SEC
Propiedad	10 años	Accionistas principales Información privilegiada	Formulario SEC 4 Formulario SEC 13D
Gestión	10 años	Equipo directivo Consejo de Administración	Formulario SEC 10-K Formulario SEC DEF 14A
Principales avances	10 años	Anuncios de empresas	Formulario SEC 8-K

^* ejemplo para los valores estadounidenses, para los no estadounidenses se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Obtenga más información aquí.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en .

Fuentes analistas

McMillan Shakespeare Limited está cubierta por 17 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

Analista	Institución
Hayden Nicholson	Bell Potter
Duncan Simmonds	BofA Global Research
Paul Buys	Canaccord Genuity

McMillan Shakespeare Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 7.3% to AU$19.72

Consensus EPS estimates increase by 16%

Price target decreased by 7.3% to AU$18.81

Consensus revenue estimates fall by 15%

Price target increased by 8.6% to AU$18.96

Price target increased by 7.8% to AU$17.45

Recent updates

The Returns At McMillan Shakespeare (ASX:MMS) Aren't Growing

McMillan Shakespeare Limited Appoints Elizabeth Spooner as Company Secretary

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2024 earnings: EPS misses analyst expectations

Price target decreased by 7.3% to AU$19.72

Mcmillan Shakespeare Limited Announces Chief Financial Officer Appointments

Upcoming dividend of AU$0.76 per share

First half dividend of AU$0.76 announced

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

McMillan Shakespeare Limited to Report First Half, 2024 Results on Feb 20, 2024

Investor sentiment improves as stock rises 22%

Consensus EPS estimates increase by 16%

First half 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 20% undervalued

Price target decreased by 7.3% to AU$18.81

Now 23% undervalued after recent price drop

Now 20% undervalued after recent price drop

When Should You Buy McMillan Shakespeare Limited (ASX:MMS)?

Upcoming dividend of AU$0.66 per share at 7.0% yield

Consensus revenue estimates fall by 15%

Price target increased by 8.6% to AU$18.96

McMillan Shakespeare (ASX:MMS) Has A Pretty Healthy Balance Sheet

Mcmillan Shakespeare Limited Announces Dividend for the Six Month Ended June 30, 2023, Payable on September22, 2023

New major risk - Financial position

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

An unknown buyer acquired Asset Finance Aggregation business of McMillan Shakespeare Limited.

Price target increased by 7.8% to AU$17.45

A Look At The Fair Value Of McMillan Shakespeare Limited (ASX:MMS)

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Upcoming dividend of AU$0.58 per share at 10.0% yield

First half 2023 earnings released: EPS: AU$0.48 (vs AU$0.39 in 1H 2022)

McMillan Shakespeare Limited, Annual General Meeting, Oct 27, 2023

Independent Non-Executive Chairman recently bought AU$62k worth of stock

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$0.74 per share

McMillan Shakespeare Limited Appoints Arlene Tansey as Independent Non-Executive Director, Effective 7 November 2022

McMillan Shakespeare Limited Announces Retirement of Tim Poole From the Board of Directors, Effective 31 August 2022

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to AU$13.63

McMillan Shakespeare Limited Declares Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on November 10, 2022

Investor sentiment improved over the past week

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Price target decreased to AU$13.01

Price target increased to AU$14.29

Price target decreased to AU$13.23

Upcoming dividend of AU$0.34 per share

McMillan Shakespeare Limited, Annual General Meeting, Oct 28, 2022

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

McMillan Shakespeare Limited Declares an Interim Fully Franked Dividend, Payable on 25 March 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of AU$0.31 per share

McMillan Shakespeare Limited (ASX:MMS) acquired Plan Tracker.

Full year 2021 earnings released: EPS AU$0.79 (vs AU$0.016 in FY 2020)

Price target increased to AU$14.84

Independent Non-Executive Director has left the company

Independent Non-Executive Director has left the company

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Non-Executive Director recently sold AU$1.5m worth of stock

New 90-day low: AU$11.30

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

First half 2021 earnings released: EPS AU$0.33 (vs AU$0.42 in 1H 2020)

McMillan Shakespeare Limited (ASX:MMS) acquired remaining 50% stake in Maxxia Limited for AUD 1.8 million.

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

McMillan Shakespeare Limited to Report Fiscal Year 2021 Results on Aug 24, 2021